Member Info for cj62

BV I don't think either NFT or MM's needs disecting. If AVA6103 does what it meant to do it is extremely hard to put valuation together. The 4 indications we are looking at have approx 500k new cases worldwide per year.

I await the initial data in let's say 6 months time

“It’s hard to win an argument with a smart person — it’s impossible with a stupid one.”

Give it up guys, just ignore the twat

“Never argue with idiots. They’ll drag you down to their level and beat you with experience.”

Ice

“Arguing with an idiot is like playing chess with a pigeon: it knocks over the pieces and struts like it won anyway.”

Tricky that should read " prosperity plunderer". Larry Fink and blackrock are the most dangerous things on this planet.

Shall we have a 'Spot the idiot' competition?

You win it thorn, no competition !!!

That's theoretical of course.

Thorn its like 99% of the other gibberish you post twat.

That does put it into perspective a little better, imagine if ava6103 replicates the animal models to a certain degree.

Oh Thorn you are whipping yourself into a frenzy. How many sets of crayons have you gone through today ? You must have written ava6000 doesn't work and half life a million times recently, if you have used your brown crayons first can you over write with other colours because iam really worried you will run out of wall space and that will definitely send out nurse bothering again and we don't want that now do we.

This program continues to garner significant interest from global pharmaceutical companies; however, the Company's strategy remains to retain 100% of AVA6103 until we begin to see readouts from the Phase 1a clinical trial. Importantly, the trial has been designed to rapidly deliver clinical data in this program.

If the above statement doesnt give you any assurances regarding commercial partnership i dont know what will. I for one can wait another 6-9 months.

Cancer Type USA (Annual Cases) Europe (Annual Cases)

Pancreatic ~67,000 ~145,000

Gastric (Stomach) ~31,500 ~161,000

Lung (overall) ~226,650 (~29,500 small-cell) ~435,000 (~56,000 small-cell)

Cervical ~14,000–15,000 ~58,000

I have to say that its a huge addressable market and if AVA 6103 is successful I would find it impossible to put a value to it.

With preliminary data from this trial anticipated in the second half of 2026.

That's after june twat

Thorn/touk you seem to have lost your biomedical skills along the way. ?

Avacta is an incredible application of biomedical engineering."

So touk you dont think it is , well give us biomedical reasoning why.

Why are you bothered thorn ? Do you not get fed up of the loop you are in ?

Yes we know it doesn't work but heyho who cares.

Bravo wyndrone you appear to be the next Warren B. Now you narcissistic half wit can you go elsewhere.

I bought nvidia at $56 and sold them $1220 and I had a lot of them Am I better than you ?

Come back when funding is sorted as no one cares for you thoughts

Why are you concerned thorn as i believe you sold up waiting until funding is sorted?

Well i fear it maybe touk ie you that mentioned it. Same as there is no dialogue with the FDA I think that ones debunked now.

Thorn you also said the IND must come first before manufacturing of ava 6103 begins but they are presently manufacturing 6103. Why ?